Brain metabolism in the cerebellum and visual cortex correlates with neuropsychological testing in patients with Alzheimer's disease
- PMID: 12813197
- DOI: 10.1097/01.mnm.0000080249.50447.99
Brain metabolism in the cerebellum and visual cortex correlates with neuropsychological testing in patients with Alzheimer's disease
Abstract
This study was designed to measure glucose metabolic deficits in areas not typically recognized as abnormal on 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) scans in patients with Alzheimer's disease (AD), and to correlate such findings with subtle neuropsychological impairment. FDG-PET scans on 38 AD patients with no clinical evidence of visual, spatial or motor deficits were acquired on the PET HEAD scanner 40 min following the intravenous administration of 115 microCi.kg-1 of FDG. All FDG-PET scans were analysed blindly using a region of interest (ROI) template with regions for the primary visual cortex (PVC), secondary visual cortex (SVC) and cerebellum. Counts from the ROIs of these regions were normalized to whole brain activity and the results were compared with psychometric and neuropsychological measures. A number of significant correlations were found between these structures and various neuropsychological measures (P<0.05). Specifically, there were significant correlations between clock drawing and the cerebellum activity; memory and activity in the PVC, SVC and cerebellum; social score and activity in the PVC and left cerebellum; judgement and activity in the right SVC and right PVC; and the overall Mini-Mental State Examination and activity in the PVC, SVC and cerebellum. The results of this study suggest that metabolism in areas not typically recognized as abnormal on FDG-PET scans in AD, such as the PVC, SVC and cerebellum, is correlated with deficits in neuropsychological function. This may have important clinical and pathophysiological implications in the study of AD and other illnesses of dementia.
Similar articles
-
Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.Exp Neurol. 2005 Feb;191 Suppl 1:S95-S103. doi: 10.1016/j.expneurol.2004.06.017. Exp Neurol. 2005. PMID: 15629765 Clinical Trial.
-
Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.Am J Psychiatry. 1996 Oct;153(10):1261-8. doi: 10.1176/ajp.153.10.1261. Am J Psychiatry. 1996. PMID: 8831432
-
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.Brain. 2006 Nov;129(Pt 11):2856-66. doi: 10.1093/brain/awl178. Epub 2006 Jul 19. Brain. 2006. PMID: 16854944
-
Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer's disease.Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S29-36. doi: 10.1016/j.jalz.2007.10.004. Epub 2007 Dec 21. Alzheimers Dement. 2008. PMID: 18631997 Review.
-
Clinical application of positron emission tomography for diagnosis of dementia.Ann Nucl Med. 2002 Dec;16(8):515-25. doi: 10.1007/BF02988628. Ann Nucl Med. 2002. PMID: 12593416 Review.
Cited by
-
Working memory and FDG-PET dissociate early and late onset Alzheimer disease patients.J Neurol. 2005 May;252(5):548-58. doi: 10.1007/s00415-005-0685-3. Epub 2005 Feb 23. J Neurol. 2005. PMID: 15726251
-
PathNet: a tool for pathway analysis using topological information.Source Code Biol Med. 2012 Sep 24;7(1):10. doi: 10.1186/1751-0473-7-10. Source Code Biol Med. 2012. PMID: 23006764 Free PMC article.
-
Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment.J Neurol. 2007 Aug;254(8):1000-8. doi: 10.1007/s00415-006-0498-z. Epub 2007 Mar 20. J Neurol. 2007. PMID: 17375260
-
Resistance, vulnerability and resilience: A review of the cognitive cerebellum in aging and neurodegenerative diseases.Neurobiol Learn Mem. 2020 Apr;170:106981. doi: 10.1016/j.nlm.2019.01.004. Epub 2019 Jan 7. Neurobiol Learn Mem. 2020. PMID: 30630042 Free PMC article. Review.
-
A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration.Eur Arch Psychiatry Clin Neurosci. 2011 Sep;261(6):433-46. doi: 10.1007/s00406-010-0184-0. Epub 2011 Jan 5. Eur Arch Psychiatry Clin Neurosci. 2011. PMID: 21207049
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical